108 related articles for article (PubMed ID: 27423613)
1. Mortality in Hungarian patients with multiple sclerosis between 1993 and 2013.
Sandi D; Zsiros V; Füvesi J; Kincses ZT; Fricska-Nagy Z; Lencsés G; Vécsei L; Bencsik K
J Neurol Sci; 2016 Aug; 367():329-32. PubMed ID: 27423613
[TBL] [Abstract][Full Text] [Related]
2. Survival and cause of death in multiple sclerosis: results from a 50-year follow-up in Western Norway.
Grytten Torkildsen N; Lie SA; Aarseth JH; Nyland H; Myhr KM
Mult Scler; 2008 Nov; 14(9):1191-8. PubMed ID: 18632781
[TBL] [Abstract][Full Text] [Related]
3. Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada.
Kingwell E; van der Kop M; Zhao Y; Shirani A; Zhu F; Oger J; Tremlett H
J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):61-6. PubMed ID: 21865212
[TBL] [Abstract][Full Text] [Related]
4. Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study.
Lunde HMB; Assmus J; Myhr KM; Bø L; Grytten N
J Neurol Neurosurg Psychiatry; 2017 Aug; 88(8):621-625. PubMed ID: 28365589
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of epilepsy in multiple sclerosis.
Mahamud Z; Burman J; Zelano J
Mult Scler Relat Disord; 2020 Feb; 38():101497. PubMed ID: 31726355
[TBL] [Abstract][Full Text] [Related]
6. Natural history of secondary-progressive multiple sclerosis.
Tremlett H; Yinshan Zhao ; Devonshire V
Mult Scler; 2008 Apr; 14(3):314-24. PubMed ID: 18208898
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival of patients with multiple sclerosis in West France.
Leray E; Morrissey S; Yaouanq J; Coustans M; Le Page E; Chaperon J; Edan G
Mult Scler; 2007 Aug; 13(7):865-74. PubMed ID: 17881399
[TBL] [Abstract][Full Text] [Related]
8. Causes that Contribute to the Excess Mortality Risk in Multiple Sclerosis: A Population-Based Study.
Kingwell E; Zhu F; Evans C; Duggan T; Oger J; Tremlett H
Neuroepidemiology; 2020; 54(2):131-139. PubMed ID: 31852000
[TBL] [Abstract][Full Text] [Related]
9. Excess mortality and cause of death in a cohort of Norwegian multiple sclerosis patients.
Smestad C; Sandvik L; Celius EG
Mult Scler; 2009 Nov; 15(11):1263-70. PubMed ID: 19812114
[TBL] [Abstract][Full Text] [Related]
10. Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM.
Sola P; Mandrioli J; Simone AM; Ferraro D; Bedin R; Annecca R; Venneri MG; Nichelli PF; Merelli E
Mult Scler; 2011 Mar; 17(3):303-11. PubMed ID: 21078694
[TBL] [Abstract][Full Text] [Related]
11. Multiple sclerosis survival: a population-based study in Sicily.
Ragonese P; Aridon P; Mazzola MA; Callari G; Palmeri B; Famoso G; Terruso V; Salemi G; D'Amelio M; Savettieri G
Eur J Neurol; 2010 Mar; 17(3):391-7. PubMed ID: 19863646
[TBL] [Abstract][Full Text] [Related]
12. Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience.
Mancardi GL; Sormani MP; Di Gioia M; Vuolo L; Gualandi F; Amato MP; Capello E; Currò D; Uccelli A; Bertolotto A; Gasperini C; Lugaresi A; Merelli E; Meucci G; Motti L; Tola MR; Scarpini E; Repice AM; Massacesi L; Saccardi R;
Mult Scler; 2012 Jun; 18(6):835-42. PubMed ID: 22127896
[TBL] [Abstract][Full Text] [Related]
13. Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated Syndrome.
Kantarci OH; Lebrun C; Siva A; Keegan MB; Azevedo CJ; Inglese M; Tintoré M; Newton BD; Durand-Dubief F; Amato MP; De Stefano N; Sormani MP; Pelletier D; Okuda DT
Ann Neurol; 2016 Feb; 79(2):288-94. PubMed ID: 26599831
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of multiple sclerosis in Santiago de Compostela (Spain).
Costa Arpín E; Naveiro Soneira J; Lema Bouzas M; González Quintela A; Prieto González JM
Acta Neurol Scand; 2020 Sep; 142(3):267-274. PubMed ID: 32392359
[TBL] [Abstract][Full Text] [Related]
15. Trends in survival and cause of death in Danish patients with multiple sclerosis.
Brønnum-Hansen H; Koch-Henriksen N; Stenager E
Brain; 2004 Apr; 127(Pt 4):844-50. PubMed ID: 14960501
[TBL] [Abstract][Full Text] [Related]
16. Survival of multiple sclerosis in Finland between 1964 and 1993.
Sumelahti ML; Tienari PJ; Wikström J; Salminen TM; Hakama M
Mult Scler; 2002 Aug; 8(4):350-5. PubMed ID: 12166507
[TBL] [Abstract][Full Text] [Related]
17. Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios.
Manouchehrinia A; Tanasescu R; Tench CR; Constantinescu CS
J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):324-31. PubMed ID: 25935887
[TBL] [Abstract][Full Text] [Related]
18. Long-term influence of combined oral contraceptive use on the clinical course of relapsing-remitting multiple sclerosis.
Gava G; Bartolomei I; Costantino A; Berra M; Venturoli S; Salvi F; Meriggiola MC
Fertil Steril; 2014 Jul; 102(1):116-22. PubMed ID: 24794311
[TBL] [Abstract][Full Text] [Related]
19. Rituximab in multiple sclerosis: A retrospective observational study on safety and efficacy.
Salzer J; Svenningsson R; Alping P; Novakova L; Björck A; Fink K; Islam-Jakobsson P; Malmeström C; Axelsson M; Vågberg M; Sundström P; Lycke J; Piehl F; Svenningsson A
Neurology; 2016 Nov; 87(20):2074-2081. PubMed ID: 27760868
[TBL] [Abstract][Full Text] [Related]
20. Anti-HHV-6 IgG titer significantly predicts subsequent relapse risk in multiple sclerosis.
Simpson S; Taylor B; Dwyer DE; Taylor J; Blizzard L; Ponsonby AL; Pittas F; Dwyer T; van der Mei I
Mult Scler; 2012 Jun; 18(6):799-806. PubMed ID: 22084489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
